A detailed history of Steward Financial Group LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Steward Financial Group LLC holds 4 shares of PRTA stock, worth $56. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4
Holding current value
$56
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 20, 2023

BUY
$47.3 - $70.6 $189 - $282
4 New
4 $0
Q1 2023

May 05, 2023

BUY
$46.97 - $58.27 $187 - $233
4 Added 133.33%
7 $0
Q4 2022

Feb 13, 2023

BUY
$52.05 - $65.0 $156 - $195
3 New
3 $0
Q2 2022

Jul 22, 2022

BUY
$22.73 - $39.98 $90 - $159
4 New
4 $0

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $657M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Steward Financial Group LLC Portfolio

Follow Steward Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Financial Group LLC with notifications on news.